These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3504554)

  • 21. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy.
    Reginold W; Lang AE; Marras C; Heyn C; Alharbi M; Mikulis DJ
    Parkinsonism Relat Disord; 2014 Feb; 20(2):222-5. PubMed ID: 24239142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
    Asato R; Akiguchi I; Masunaga S; Hashimoto N
    J Neural Transm (Vienna); 2000; 107(12):1427-36. PubMed ID: 11458995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
    Cosottini M; Ceravolo R; Faggioni L; Lazzarotti G; Michelassi MC; Bonuccelli U; Murri L; Bartolozzi C
    Acta Neurol Scand; 2007 Jul; 116(1):37-42. PubMed ID: 17587253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort.
    Kaasinen V; Kangassalo N; Gardberg M; Isotalo J; Karhu J; Parkkola R; Sonninen P
    Neurol Sci; 2015 Jul; 36(7):1251-3. PubMed ID: 25805708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
    Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
    Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling trajectories of regional volume loss in progressive supranuclear palsy.
    Josephs KA; Xia R; Mandrekar J; Gunter JL; Senjem ML; Jack CR; Whitwell JL
    Mov Disord; 2013 Jul; 28(8):1117-24. PubMed ID: 23568852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of atypical progressive supranuclear palsy with degeneration of the fronto-pontine tracts, and without grumose degeneration of the dentate nucleus].
    Inagaki T; Ishino H; Iijima M; Seno H; Kikumoto O; Yoshinaga J; Matsuura H; Tachiyama Y
    No To Shinkei; 1996 Nov; 48(11):1037-45. PubMed ID: 8951896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive supranuclear palsy.
    Duvoisin RC; Golbe LI; Lepore FE
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):547-54. PubMed ID: 3315157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Parkinson's disease and progressive supranuclear palsy with magnetic resonance imaging: the first Brazilian experience.
    Barsottini OG; Ferraz HB; Maia AC; Silva CJ; Rocha AJ
    Parkinsonism Relat Disord; 2007 Oct; 13(7):389-93. PubMed ID: 17275393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An elderly patient with progressive supranuclear palsy without neurological signs].
    Niizato K; Kuroki N; Arai T; Kase K; Iritani S; Ikeda K
    No To Shinkei; 1997 Sep; 49(9):829-33. PubMed ID: 9311001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
    Hassan A; Parisi JE; Josephs KA
    Neurocase; 2012; 18(6):478-88. PubMed ID: 22181323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Grassi M; Parnetti L; Agosti C; Alberici A; Premi E; Bonuccelli U; Gasparotti R; Calabresi P; Di Luca M; Padovani A
    J Alzheimers Dis; 2010; 22(1):195-203. PubMed ID: 20847421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progressive supranuclear palsy: a clinical, natural history and disability study].
    Macia F; Ballan G; Yekhlef F; Delmer O; Vital C; Lagueny A; Tison F
    Rev Neurol (Paris); 2003 Jan; 159(1):31-42. PubMed ID: 12618651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alexander disease with a novel GFAP insertion-deletion mutation mimicking progressive supranuclear palsy.
    Shiina A; Ishikawa D; Ishizawa K; Kasahara H; Fujita Y; Mizuta I; Yoshida T; Ikeda Y
    Clin Neurol Neurosurg; 2024 May; 240():108261. PubMed ID: 38599043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebral blood flow pattern in progressive supranuclear palsy].
    Okada K; Kobayashi S; Yamashita K; Fukuda H; Suyama N
    Rinsho Shinkeigaku; 1991 Jun; 31(6):597-602. PubMed ID: 1934773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
    Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
    Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.